Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
May 4, 2022
Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a new study led byUTHealth Houston.
May 3, 2022
休斯beplay苹果手机能用吗顿Uthealth的研究团队aims to increase social support and improve mental health among stroke survivors and their caregivers by customizing an existing virtual environment filled with fun, interactive ways to connect with others.
May 3, 2022
A stroke and subsequent brain injury qualified 65-year-old Linda Carmichael for a national, randomized clinical trial led locally bySunil A. Sheth, MD, withUTHealth Houston. The trial is investigating the safety and efficacy of endovascular thrombectomy plus medical management compared to medical management alone in certain LVO stroke patients.
April 25, 2022
A five-year, $2.85 million grant to use novel technology to study babies with hydrocephalus has been awarded to a team ofUTHealth Houstonbeplay苹果手机能用吗美国国立卫生研究院（NIH）的一部分，国家神经系统疾病与中风研究所的研究人员。
April 18, 2022
弗兰克·威廉姆斯（Frank Williams）在教堂里长大了键盘，但到13岁时，他被介绍给非法物质，并开始在他的高中一年级开始出售大麻。十年后，威廉姆斯（Williams）出售海洛因，并通过他所谓的“摇动习惯”慢慢沉迷于这种物质 - 这是当物质渗入您的毛孔中，这么多接触它。
April 13, 2022
一项为期五年，210万美元beplay苹果手机能用吗在德克萨斯州。
April 13, 2022
一项为期五年，1300万美元的赠款，用于研究某些传染性因素如何发展为传播慢性浪费疾病（CWD）的赠款已被授予UTHealth Houstonresearch team led by Claudio Soto, PhD, from the National Institutes of Health (NIH).
April 12, 2022
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington’s disease, according to a recent international study led byUTHealth Houstonbeplay苹果手机能用吗医学博士研究员Erin Furr刺激，他代表Kinect-HD Huntington研究小组担任首席研究员。
March 31, 2022
Using a 1-millimeter-sized wireless implant to stimulate peripheral nerves from within blood vessels has the potential to treat neuropathic pain resistant to medical therapy, according to a team of multi-institutional researchers including Sunil A. Sheth, MD, ofUTHealth Houston.
March 30, 2022
A three-year, $1.6 million grant to identify patients at risk for a serious secondary neurological complication that can arise after subarachnoid hemorrhage (SAH) has been awarded toUTHealth Houstonbeplay苹果手机能用吗研究员h·亚历克斯·崔国家Insti医学博士tutes of Health (NIH).
Use the form below to perform a new search.